458 related articles for article (PubMed ID: 17106544)
1. The significance of documenting clinical appearance of the uterine cervix in the cervical cytology form.
Al-Kadri HM; Hajeer AH; Al-Hawashim NS; Salem HH
Saudi Med J; 2006 Nov; 27(11):1698-702. PubMed ID: 17106544
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU
Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer screening with pattern of pap smear. Review of multicenter studies.
Altaf FJ
Saudi Med J; 2006 Oct; 27(10):1498-502. PubMed ID: 17013471
[TBL] [Abstract][Full Text] [Related]
4. Early detection of precursors of cervical cancer with cervical cytology and visual inspection of cervix with acetic Acid.
Dhaubhadel P; Vaidya A; Choudhary P
JNMA J Nepal Med Assoc; 2008; 47(170):71-6. PubMed ID: 18709035
[TBL] [Abstract][Full Text] [Related]
5. Profile of Pap smear cytology in the Western region of Saudi Arabia.
Jamal A; Al-Maghrabi JA
Saudi Med J; 2003 Nov; 24(11):1225-9. PubMed ID: 14647558
[TBL] [Abstract][Full Text] [Related]
6. [Follow-up not according to guidelines after an abnormal cervix smear].
Kreuger FA; Beerman H; Nijs HG; Wijnen JA
Ned Tijdschr Geneeskd; 1996 Apr; 140(15):833-6. PubMed ID: 8668277
[TBL] [Abstract][Full Text] [Related]
7. Comparison of visual inspection and Papanicolau (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned?
Perkins RB; Langrish SM; Stern LJ; Figueroa J; Simon CJ
Trop Med Int Health; 2007 Sep; 12(9):1018-25. PubMed ID: 17875013
[TBL] [Abstract][Full Text] [Related]
8. Reporting normal endometrial cells in Pap smears: an outcome appraisal.
Gomez-Fernandez CR; Ganjei-Azar P; Capote-Dishaw J; Averette HE; Nadji M
Gynecol Oncol; 1999 Sep; 74(3):381-4. PubMed ID: 10479497
[TBL] [Abstract][Full Text] [Related]
9. Histologic implications of Pap smears classified as atypical glandular cells.
Haidopoulos DA; Stefanidis K; Rodolakis A; Pilalis A; Symiakaki I; Diakomanolis E
J Reprod Med; 2005 Jul; 50(7):539-42. PubMed ID: 16130853
[TBL] [Abstract][Full Text] [Related]
10. Cervical changes associated with progestagen-only contraceptives: a team approach.
Darwish A; Labeeb S; Galal M; Rashad H; Hassan S
Contraception; 2004 Feb; 69(2):121-7. PubMed ID: 14759616
[TBL] [Abstract][Full Text] [Related]
11. Cytopathological pattern of cervical Pap smear according to the Bethesda system in Southwestern Saudi Arabia.
Elhakeem HA; Al-Ghamdi AS; Al-Maghrabi JA
Saudi Med J; 2005 Apr; 26(4):588-92. PubMed ID: 15900366
[TBL] [Abstract][Full Text] [Related]
12. The prevention of cervical cancer: the place of the cytological smear test.
Hudson E
Clin Obstet Gynaecol; 1985 Mar; 12(1):33-51. PubMed ID: 3888487
[TBL] [Abstract][Full Text] [Related]
13. Clinical and histological significance of atypical glandular cell on Pap smear.
Behtash N; Nazari Z; Fakhrejahani F; Khafaf A; Azar EG
Aust N Z J Obstet Gynaecol; 2007 Feb; 47(1):46-9. PubMed ID: 17261100
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
[TBL] [Abstract][Full Text] [Related]
15. Cervical cytopathology reporting systems. Helping or hindering patient management?
Molodysky E; Bridges-Webb C
Aust Fam Physician; 1997 Jan; 26 Suppl 1():S7-11. PubMed ID: 9009029
[TBL] [Abstract][Full Text] [Related]
16. [Cervical cancer screening and associated treatment costs in France].
Bergeron C; Breugelmans JG; Bouée S; Lorans C; Bénard S; Rémy V
Gynecol Obstet Fertil; 2006 Nov; 34(11):1036-42. PubMed ID: 17070085
[TBL] [Abstract][Full Text] [Related]
17. [Follow up after an abnormal pap smear: time interval acceptable, nature of follow up leaves room for improvement].
Geertsen M; Bais AG; Beerman H; Helmerhorst TJ
Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2430-4. PubMed ID: 14694554
[TBL] [Abstract][Full Text] [Related]
18. [Cervix smears with mild atypia classified as Pap-class IIIA: results of a changed policy].
Doornewaard H; Woudt JM; Sie-Go DM; Kooijman CD
Ned Tijdschr Geneeskd; 1991 Sep; 135(36):1642-5. PubMed ID: 1922503
[TBL] [Abstract][Full Text] [Related]
19. [Less pap-2 results ('minor abnormalities') in the population screening for cervical cancer since the introduction of new guidelines in 1996].
Bos AB; van Ballegooijen M; van den Akker-van Marle ME; Habbema JD
Ned Tijdschr Geneeskd; 2002 Aug; 146(34):1586-90. PubMed ID: 12224483
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of visual inspection of the cervix using acetic acid in cervical cancer screening: a comparison with cervical cytology.
Akinola OI; Fabamwo AO; Oshodi YA; Banjo AA; Odusanya O; Gbadegesin A; Tayo A
J Obstet Gynaecol; 2007 Oct; 27(7):703-5. PubMed ID: 17999297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
